261 related articles for article (PubMed ID: 28915495)
1. Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using
Maria RM; Altei WF; Selistre-de-Araujo HS; Colnago LA
J Pharm Biomed Anal; 2017 Nov; 146():324-328. PubMed ID: 28915495
[TBL] [Abstract][Full Text] [Related]
2. Effects of Doxorubicin, Cisplatin, and Tamoxifen on the Metabolic Profile of Human Breast Cancer MCF-7 Cells As Determined by
Maria RM; Altei WF; Selistre-de-Araujo HS; Colnago LA
Biochemistry; 2017 Apr; 56(16):2219-2224. PubMed ID: 28379688
[TBL] [Abstract][Full Text] [Related]
3. Characterization of metabolic profile of intact non-tumor and tumor breast cells by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy.
Maria RM; Altei WF; Andricopulo AD; Becceneri AB; Cominetti MR; Venâncio T; Colnago LA
Anal Biochem; 2015 Nov; 488():14-8. PubMed ID: 26247715
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS
Gogiashvili M; Edlund K; Gianmoena K; Marchan R; Brik A; Andersson JT; Lambert J; Madjar K; Hellwig B; Rahnenführer J; Hengstler JG; Hergenröder R; Cadenas C
Anal Bioanal Chem; 2017 Feb; 409(6):1591-1606. PubMed ID: 27896396
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic studies of patient material by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy.
Keun H
Methods Enzymol; 2014; 543():297-313. PubMed ID: 24924139
[TBL] [Abstract][Full Text] [Related]
6. Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high-resolution magic angle spinning
Gogiashvili M; Horsch S; Marchan R; Gianmoena K; Cadenas C; Tanner B; Naumann S; Ersova D; Lippek F; Rahnenführer J; Andersson JT; Hergenröder R; Lambert J; Hengstler JG; Edlund K
NMR Biomed; 2018 Feb; 31(2):. PubMed ID: 29206323
[TBL] [Abstract][Full Text] [Related]
7. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
8. [Study of malignant and normal tissues of the rectum using NMR spectroscopy].
Gao XX; He WY; Yao HW; Du JK; Zhao MX; Qi J; Li HZ; Xu YZ; Wu JG
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Sep; 28(9):2201-6. PubMed ID: 19093594
[TBL] [Abstract][Full Text] [Related]
9. Metabolic markers of MG-63 osteosarcoma cell line response to doxorubicin and methotrexate treatment: comparison to cisplatin.
Lamego I; Duarte IF; Marques MP; Gil AM
J Proteome Res; 2014 Dec; 13(12):6033-45. PubMed ID: 25382592
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Profiling of Cells in Response to Drug Treatment using
Vermathen M; Diserens G; Vermathen P; Furrer J
Chimia (Aarau); 2017 Mar; 71(3):124-129. PubMed ID: 28351458
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.
Yoon H; Yoon D; Yun M; Choi JS; Park VY; Kim EK; Jeong J; Koo JS; Yoon JH; Moon HJ; Kim S; Kim MJ
PLoS One; 2016; 11(7):e0159949. PubMed ID: 27459480
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR Spectroscopy.
Mun JH; Lee H; Yoon D; Kim BS; Kim MB; Kim S
PLoS One; 2016; 11(3):e0150328. PubMed ID: 26934749
[TBL] [Abstract][Full Text] [Related]
13. Quantitative NMR-Based Metabolomics on Tissue Biomarkers and Its Translation into In Vivo Magnetic Resonance Spectroscopy.
Serkova NJ; Davis DM; Steiner J; Agarwal R
Methods Mol Biol; 2019; 1978():369-387. PubMed ID: 31119675
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of listeria rhombencephalitis in small ruminants by
Precht C; Diserens G; Vermathen M; Oevermann A; Lauper J; Vermathen P
NMR Biomed; 2018 Dec; 31(12):e4023. PubMed ID: 30328643
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
16.
Vermathen M; von Tengg-Kobligk H; Hungerbühler MN; Vermathen P; Ruprecht N
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833859
[TBL] [Abstract][Full Text] [Related]
17. Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
Esmaeili M; Bathen TF; Engebråten O; Mælandsmo GM; Gribbestad IS; Moestue SA
Magn Reson Med; 2014 Jun; 71(6):1973-81. PubMed ID: 23878023
[TBL] [Abstract][Full Text] [Related]
18. Biochemical changes in selenite cataract model measured by high-resolution MAS H NMR spectroscopy.
Fris M; Tessem MB; Saether O; Midelfart A
Acta Ophthalmol Scand; 2006 Oct; 84(5):684-92. PubMed ID: 16965502
[TBL] [Abstract][Full Text] [Related]
19. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
20. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
